Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity

by Yuhei eNishimura, Yuhei eNishimura, Yuhei eNishimura, Yuhei eNishimura, Yuhei eNishimura, Shota eSasagawa, Michiko eAriyoshi, Sayuri eIchikawa, Yasuhito eShimada, Koki eKawaguchi, Reiko eKawase, Reiko eYamamoto, Takuma eUehara, Takaaki eYanai, Ryoji eTakata, Toshio eTanaka, Toshio eTanaka, Toshio eTanaka, Toshio eTanaka, Toshio eTanaka
Published 2015-09-01